The Goods and Services Tax Council after its 50th meet in New Delhi on Tuesday has agreed to exempt GST on import of cancer drug Dinutuximab, and Food for Special Medical Purposes (FSMP) used in the treatment of rare diseases. Currently, the drug attracts a 12% integrated GST.
Recent Posts
- Govt launches carbon market portal,domestic market to start within next 4 months
- FPIs pull out Rs 35,475 cr this week from Indian markets, March outflows hit Rs 88,180 cr
- Foetus older than 5 months would be treated as ‘person’ in eyes of law,entitled for compensation: HC
- West Asia Conflict:Trump indicates possible end to conflict,Oil price spike continues
- RiverStone International launches Australian presence with company acquisition, leadership appointment and legacy transaction with Zurich
Categories
- Articles
- Banking & Bancassurance
- Blog
- Breaking News!
- Briefs
- Climate, Environment, Renewable Energy
- Data
- Disaster & Management
- Eco/Invest/Demography
- Editorial
- Events
- Facts
- Features
- Health
- Indian News
- Intermediaries
- International News
- Interviews
- Life
- Main Menu
- Non-Life
- Pandemic
- Pension & Social Security
- Policy
- Regulation
- Reinsurance
- Risk Management
- Simple
- Technology
- Trends, Facts
- Uncategorized
- Wealth Management/ Philanthropy
- Workplace/Employee Benefits